26RS SB 211

Senate Bill 211

Actions

Last Action	02/19/26: to Committee on Committees (S)
Title	AN ACT relating to coverage for prescription drugs.
Bill Documents	Introduced
Bill Request Number	2131
Sponsor	C. Richardson
Summary of Original Version	Create a new section of Subtitle 17A of KRS Chapter 304 to require health plans to include a generic drug or biosimilar on the plan's formulary under specified circumstances; define terms; establish cost-sharing requirements when a generic drug or biosimilar is required to be placed on the health plan's formulary; prohibit a health plan from imposing any prior authorization, step therapy, or other limitation on coverage for a generic drug or biosimilar required to be placed on the health plan's formulary or imposing any restriction on a pharmacist or pharmacy that makes it more difficult for the insured to obtain coverage or access to the generic drug or biosimilar compared to the reference drug or product; amend KRS 304.17C-125, 164.2871, and 18A.225 to require limited health service benefit plans, self-insured group health plans offered by a state postsecondary education institution, and the state employee health plan to comply with the requirements for generic drugs and biosimilars; direct that the Act applies to health plans issued or renewed on or after January 1, 2027; EFFECTIVE, January 1, 2027.
Index Headings of Original Version	Drugs And Medicines - Generic drugs and biosimilars, insurance, formulary placement Education, Higher - Self-insured group health plan, generic drugs and biosimilars, formulary placement Effective Dates, Delayed - Generic drugs and biosimilars, insurance, formulary placement, January 1, 2027 Health And Medical Services - Generic drugs and biosimilars, insurance, formulary placement Insurance, Health - Generic drugs and biosimilars, formulary placement Pharmacists - Generic drugs and biosimilars, insurance, formulary placement State Employees - Health plan, generic drugs and biosimilars, formulary placement